share_log

Unicycive Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Logos Global Management LP(9.9%),Logos Global Management GP LLC(9.9%), etc.

Unicycive Therapeutics | SC 13G:超过5%持股股东披露文件-Logos Global Management LP(9.9%),Logos Global Management GP LLC(9.9%)等

SEC announcement ·  01/22 00:00
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息